AstraZeneca launches Evinova, a digital health company aiming to expedite clinical trials using AI. The spin-off will independently operate within AstraZeneca, utilizing AI to design studies, automate cost calculations, and assess feasibility for drug testing. CEO Pascal Soriot highlights the potential for digital solutions to accelerate medicine development, improve patient care, drive healthcare transformation, and reduce carbon emissions. Evinova focuses on enhancing healthcare through technologies like wearables, telemedicine, and virtual reality. For further details 👇🏾
